Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Tipifarnib

EU orphan designation number: EU/3/05/269   
Active ingredient: Tipifarnib
Indication: Treatment of acute myeloid leukaemia
Sponsor: Janssen-Cilag International NV
Turnhoutseweg 30, B-2340 Beerse, BelgiŽ

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/03/2005 Centralised Orphan - Designation EMEA/OD/098/04 (2005)807 of 10/03/2005